PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Calpain inhibitor MDL28170 improves the transplantation-mediated therapeutic effect of bone marrow-derived mesenchymal stem cells following traumatic brain injury.

Rat / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30876457 ↗2019Reported benefit

Calpain inhibitor MDL28170 improves the transplantation-mediated therapeutic effect of bone marrow-derived mesenchymal stem cells following traumatic brain injury.

RatTBIWeight-drop / impact-accelerationSprague-Dawleymalen = Total not stated; 3 to 4 rats per group for individual assa…intracranial microinjection at lesion site, 1.0 mm depth; BMSCs engrafted into injury epicentre at 1 uL/min1.0 uL of 50 mM MDL28170 in 20 percent DMSO; BMSC dose repo…MDL28170 at 30 min post-injury; BMSCs at 24 h post-injury

Model: Weight-drop parietal contusion, 5 mm burr hole right parietal bone, 50 g hammer from 30 cm

MDL28170 preconditioning reduced pro-inflammatory cytokines and graft apoptosis, increased survival of transplanted BMSCs and reduced lesion cavity and neurological deficit compared with BMSCs alone.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.